MMP2 and cancer: All these nanoplatforms employ gatekeeper systems containing matrix metalloproteinase (MMP)-2 and -9 protease linkers, based on the observation that these MMPs are frequently upregulated in cancer [35,36] and the fact that MMP cleavages site are well described.